LIPID-PEROXIDATION ABNORMALITIES IN HEMODIALYZED PATIENTS

被引:127
|
作者
PAUL, JL
SALL, ND
SONI, T
POIGNET, JL
LINDENBAUM, A
MAN, NK
MOATTI, N
RAICHVARG, D
机构
[1] FAC SCI PHARMACEUT & BIOL CHATENAY MALABRY,BIOCHIM LAB,CHATENAY MALABRY,FRANCE
[2] UNIV CHEIKH ANTA DIOP,BIOCHIM MED LAB,DAKAR,SENEGAMBIA
[3] HOP BECLERE,BIOCHIM LAB,CLAMART,FRANCE
[4] HOP NECKER ENFANTS MALAD,DEPT NEPHROL,INSERM,U90,F-75730 PARIS 15,FRANCE
[5] HOP COCHIN,BIOCHIM LAB,F-75674 PARIS 14,FRANCE
[6] CTR MED E RIST,PARIS,FRANCE
来源
NEPHRON | 1993年 / 64卷 / 01期
关键词
LIPID PEROXIDATION; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; HEMODIALYSIS;
D O I
10.1159/000187287
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In order to test the existence of a possible oxidative damage during hemodialysis, plasma conjugated dienes (CD), plasma and red blood cell (RBC) thiobarbituric acid (TBA) reactants were investigated in 25 patients receiving regular dialysis treatment (RDT). The RBC TBA reactant concentration was significantly increased in RDT patients in comparison with healthy subjects. The extracellular antioxidant systems were evaluated by the assay of plasma antioxidant activity, plasma tocopherol, urate, transferrin, haptoglobin and ceruloplasmin levels. Except urate and transferrin, none of these parameters were different between the two groups. On the other hand, in RDT patients, RBC superoxide dismutase (SOD) and glutathione peroxidase (GPX) activities were significantly lower than in healthy subjects. There was an inverse correlation between decreased RBC GPX and RBC TBA reactant concentration. These results show in RDT patients the existence of an oxidizing stress, mainly intracellular, which could be due, in part, to a decrease in SOD and GPX activities.
引用
收藏
页码:106 / 109
页数:4
相关论文
共 50 条
  • [41] THE EFFECT OF BICYCLE ERGOMETRY ON LIPID-PEROXIDATION IN CORONARY PATIENTS
    BARDIN, EV
    KUKHTA, VK
    MOROZKINA, TS
    FEDIN, PG
    KHRUTSKAYA, MS
    POLYAKOVA, ZI
    LISITSINA, LP
    ZAKHARENKO, IV
    VOLOKHOVICH, GS
    KARDIOLOGIYA, 1987, 27 (12) : 55 - 58
  • [42] EVIDENCE FOR SYSTEMIC LIPID-PEROXIDATION IN PATIENTS AND ANIMALS WITH CANCER
    FOSSEL, ET
    MCDONAGH, J
    CLINICAL RESEARCH, 1991, 39 (02): : A435 - A435
  • [43] CORRECTION OF LIPID-PEROXIDATION DISORDERS IN PATIENTS WITH ULCER DISEASE
    TOLMACH, DV
    CHUBENKO, SS
    ZHDANIUK, YI
    VRACHEBNOE DELO, 1991, (02): : 86 - 87
  • [44] CHANGE IN LIPID-PEROXIDATION IN PATIENTS WITH PRIMARY DEGENERATIVE OSTEOARTHROSIS
    RUDYK, BI
    FILCHAGIN, NM
    SABADYSHIN, RA
    TERAPEVTICHESKII ARKHIV, 1988, 60 (09) : 110 - 113
  • [45] LIPID-PEROXIDATION IN PATIENTS UNDERGOING ANESTHESIA WITH HALOTHANE OR ISOFLURANE
    LIPPA, S
    DORDONI, PL
    ORADEI, A
    AURELI, V
    BRACALI, AM
    PELOSI, G
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1990, 7 (06) : 441 - 446
  • [46] INDEXES OF CERULOPLASMIN AND LIPID-PEROXIDATION IN PATIENTS WITH PULMONARY TUBERCULOSIS
    KHARAKTER, JZ
    SKORAYA, RI
    PLATONOVA, IL
    VRACHEBNOE DELO, 1989, (10): : 55 - 57
  • [47] LIPID-PEROXIDATION OF THE ERYTHROCYTIC MEMBRANES IN PATIENTS WITH HYPERTENSIVE DISEASE
    SIURIN, AA
    KULAGIN, YI
    KUZNETSOV, NS
    ANIKIN, EI
    KABELIUZHENKO, SB
    SHUR, MA
    VRACHEBNOE DELO, 1988, (12): : 24 - 26
  • [48] LIPID-PEROXIDATION AND ANTIOXIDANTS IN CONTINUOUS AMBULATORY DIALYSIS PATIENTS
    TAYLOR, JE
    SCOTT, N
    BRIDGES, A
    HENDERSON, IS
    STEWART, WK
    BELCH, JJF
    PERITONEAL DIALYSIS INTERNATIONAL, 1992, 12 (02): : 252 - 256
  • [49] BIOMICROSCOPY DATA OF THE CONJUNCTIVA AND LIPID-PEROXIDATION IN PATIENTS WITH STENOCARDIA
    GORB, GD
    RUDENKO, NN
    VRACHEBNOE DELO, 1987, (04): : 47 - 49
  • [50] SIMVASTATIN DOES NOT INCREASE LIPID-PEROXIDATION IN UREMIC PATIENTS
    MOUNEIMNE, A
    SIRAJEDDINE, K
    RICHARD, MJ
    TRICOT, F
    DENIS, MC
    CORDONNIER, D
    NEPHRON, 1993, 63 (04): : 477 - 477